Feasibility and Usability of a Pedometer in a Cardiovascular Disease Prevention Program for French-speaking Canadians
NCT ID: NCT02837471
Last Updated: 2022-02-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
54 participants
INTERVENTIONAL
2016-10-31
2019-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Integration of Telemedicine and Home-Based Cardiac Rehabilitation: Feasibility, Efficacy, and Adherence
NCT05972070
Effects of Remote Patient Monitoring on Heart Failure Management
NCT00778986
Vis-Rx Post-Market Evaluation
NCT04533503
SEMEiotic Oriented Technology for Individual's CardiOmetabolic Risk Self- assessmeNt and Self-monitoring
NCT02818504
The Use of a Monitoring Device by General Practitioners During Out-of-hours Care
NCT05222711
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention group, PiezoRx device
Participants will use the PiezoRx pedometer at leisure for 12 weeks, and receive the standard care of the FrancoForme cardiac prevention and rehabilitation program.
PiezoRx medical grade pedometer
Participants will be asked to freely use the PiezoRx medical grade pedometer for 12 weeks.
Participants have access to a personal account created online and can record the daily steps count and physical activity.
Participants will receive the standard care by the FrancoForme Cardiovascular rehabilitation and prevention program
Control group, Standard care
Participants will receive the standard care of the FrancoForme Cardiovascular disease prevention and rehabilitation program.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
PiezoRx medical grade pedometer
Participants will be asked to freely use the PiezoRx medical grade pedometer for 12 weeks.
Participants have access to a personal account created online and can record the daily steps count and physical activity.
Participants will receive the standard care by the FrancoForme Cardiovascular rehabilitation and prevention program
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ≥18 years;
* Existing atherosclerotic vascular disease or ≥1 risk factor for CVD (e.g., family history of premature CVD, age \[sex dependent\], smoking, sedentary lifestyle, diabetes, hypertension, hypercholesterolemia, overweight/obesity);
* Live in the Champlain Region and attending the onsite FrancoForme® intake;
* Have a family physician or nurse practitioner (to order blood tests and titrate medications);
* Patient agrees to sign informed consent.
Exclusion Criteria
* Unable to engage in physical activity;
* Does not have access to the internet;
* Unable to attend follow-up visits;
* Unable to provide written, informed consent.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
StepsCount Inc
UNKNOWN
Ottawa Heart Institute Research Corporation
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jennifer Reed
Associate Scientist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jennifer Reed, PhD MEd, CS
Role: PRINCIPAL_INVESTIGATOR
Ottawa Heart Institute Research Corporation
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Ottawa Heart Insititue
Ottawa, Ontario, Canada
University of Ottawa Heart Institute
Ottawa, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20160491
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.